壳聚糖
化学
最小抑制浓度
核化学
生物膜
抗菌剂
自愈水凝胶
表皮葡萄球菌
抗菌活性
卡拉胶
微生物学
金黄色葡萄球菌
生物化学
细菌
高分子化学
有机化学
生物
遗传学
作者
Noura Y. Elmehbad,Nadia A. Mohamed,Nahed A. Abd El‐Ghany,Marwa M. Abdel‐Aziz
标识
DOI:10.1016/j.ijbiomac.2023.125582
摘要
Two novel chemically cross-linked chitosan hydrogels were successfully prepared via insertion of oxalyl dihydrazide moieties between chitosan Schiff's base chains (OCsSB) and between chitosan chains (OCs). For more modification, two different concentrations of ZnO nanoparticles (ZnONPs) were loaded into OCs to obtain OCs/ZnONPs-1 % and OCs/ZnONPs-3 % composites. The prepared samples were recognized using elemental analyses, FTIR, XRD, SEM, EDS and TEM. Their inhibitory action against microbes and biofilms were classified as: OCs/ZnONPs-3 % > OCs/ZnONPs-1 % > OCs > OCsSB > chitosan. OCs has inhibition activity similar to Vancomycin of minimum inhibitory concentration (MIC) value of 3.9 μg/mL against P. aeruginosa. OCs exhibited minimum biofilm inhibitory concentration (MBIC) values (from 31.25 to 62.5 μg/mL) less than that of OCsSB (from 62.5 to 250 μg/mL) which lower than that of chitosan (from 500 to 1000 μg/mL) against S. epidermidis, P. aeruginosa and C. albicans. OCs/ZnNPs-3 % showed MIC value (that caused 100 % inhibition of Clostridioides difficile, C. difficile) of 0.48 μg/mL much lower than Vancomycin (1.95 μg/mL). Both OCs and OCs/ZnONPs-3 % composite were safe on normal human cells. Thus, inclusion of oxalyl dihydrazide and ZnONPs into chitosan greatly reinforced its antimicrobial activity. This is a good strategy to accomplish adequate systems for competing traditional antibiotics.
科研通智能强力驱动
Strongly Powered by AbleSci AI